Antidiabetic drug classes show varied associations with liver outcomes in T2DM, with SGLT2 inhibitors and GLP-1 RA ranking highest.

A study published in Rheumatology & Autoimmunity challenges the assumption that achieving clinical remission in rheumatoid ...

In January 2022, the U.S. Food and Drug Administration (FDA) released finalized guidance on premarket pathways for combination products. While the guidance is not binding, it provides industry ...

Especially unusual for an administration known for drastic actions against potential drug importers in both the Pacific Ocean ...